Healthcare-associated Infectious Disease Diagnostics Market By Infection Type (Urinary Tract Infections, Surgical Site Infections, Hospital-acquired Pneumonia, Blood Stream Infections, Gastrointestinal Infections, and Other Healthcare-associated Infections), By Product Type (Consumables and Analyzers/Instruments), By Test Type (Traditional Diagnostics and Molecular Diagnostics), By End-User Type (Hospitals, Clinics, ASCs, and Others), and By Region - Trends, Analysis and Forecast till 2030

The market for infectious disease diagnostics related to healthcare is divided into five regions: North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Due to the high frequency of infectious diseases and the existence of an adequate healthcare system in the region, North America presently leads the world in terms of income generated by contagious disease diagnostics. According to estimations, the European market has the second-highest revenue share in the world market. The markets in Asia Pacific, Latin America, and the Middle East & Africa are the next major revenue shareholders. The Asia Pacific market is anticipated to grow at the quickest rate in terms of revenue due to the rise in government programs aimed at improving healthcare facilities in the region's developing economies and the rising frequency of infectious diseases.